NCT06231979View on ClinicalTrials.gov

Adding Dexmedetomidine to Bupivacaine for Bilateral Erector Spinae Block

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

February 25, 2024

Primary Completion Date

January 1, 2025

Study Completion Date

October 1, 2025

Conditions
Erector Spinae BlockLumbar Fusion SurgeriesDexmedetomidine
Interventions
DRUG

Dexmedetomidine

1 μg/kg Dexmedetomidine per side in erector spinae block

DRUG

Bupivacain

18 mL of bupivacaine 0.25 % per side in erector spinae block

DRUG

Normal saline

2 ml normal saline 0.9% per side in erector spinae block

All Listed Sponsors
lead

Assiut University

OTHER